The Effects of YAP and Its Related Mechanisms in Central Nervous System Diseases

Jiayan Jin1,2, Xiaoxuan Zhao1,2, Huifang Fu1,3

  • 1Department of Forensic Science, School of Basic Medical Science, Wenzhou Medical University, Wenzhou, China.

Insights

Yes-associated protein (YAP), a key part of the Hippo pathway, is vital for central nervous system (CNS) function. This review explores YAP

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Cell Biology

Background:

  • Yes-associated protein (YAP) is a critical downstream effector of the Hippo signaling pathway.
  • YAP significantly influences central nervous system (CNS) physiology and pathology.
  • Its precise roles and mechanisms in CNS diseases remain largely unclear.

Purpose of the Study:

  • To systematically review the biological features of YAP in the CNS.
  • To elucidate the pathological roles and underlying mechanisms of YAP in both normal and diseased CNS.
  • To identify potential molecular targets and therapeutic strategies for CNS disorders.

Main Methods:

  • Comprehensive literature review of YAP in the central nervous system.
  • Analysis of YAP's involvement in cell proliferation, differentiation, migration, and apoptosis.
  • Synthesis of current knowledge on YAP's function in CNS diseases.

Main Results:

  • YAP regulates fundamental cellular processes in the CNS, including proliferation, differentiation, migration, and apoptosis.
  • Evidence suggests YAP plays a complex role in various CNS pathologies.
  • Specific molecular mechanisms linking YAP to CNS disease pathogenesis are being uncovered.

Conclusions:

  • YAP is a crucial regulator in the CNS with significant implications for disease.
  • Understanding YAP's mechanisms offers potential for novel therapeutic interventions in CNS diseases.
  • Further research into YAP's role could lead to targeted treatments for neurological disorders.

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
2.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
699
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.8K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.6K